Edg Pharmaceuticals (India) Private Limited, a active private limited company, was established on 29 August 2011 in Coimbatore, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231TZ2011PTC017367. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.70 M.
Formerly known as Edg Pharmaceuticals (India)Limited. It upholds a compliant status. Its leadership includes Nallagounder Palaniswami Arun (Director), Deivasigamani Palaniswamy (Director), Palanisami Thavamanidevi (Director). Past directors included Purani P Palaniswami, Mohan S Gounder. It holds ₹7.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 131, Kalidass Road Ramnagar, Coimbatore, Coimbatore, Tamil Nadu, 641009.
U24231TZ2011PTC017367
017367
29 August 2011
₹5.00 M
₹3.70 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Edg Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nallagounder Palaniswami Arun | Director | 29 Aug 2011 | Current |
| Deivasigamani Palaniswamy | Director | 29 Aug 2011 | Current |
| Palanisami Thavamanidevi | Director | 29 Aug 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Aug 2024 | Past |
| Pramod Abcsdd | Director | 05 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Edg Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.1% increase. The company also saw a substantial improvement in profitability, with a 74.72% increase in profit. The company's net worth Soared by an impressive increase of 190.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Edg Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2012 | City Union Bank Limited | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Edg Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Edg Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edg Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Edg Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Edg Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore. was recorded as a recent event.
The activity A charge with City Union Bank Limited of Rs. 7.50 M registered on 04 Jul 2012 with Charge ID 10370463 was modified on 28 Aug 2020. was completed.
A charge with City Union Bank Limited amounted to Rs. 7.50 M with Charge ID 10370463 was registered on 04 Jul 2012. was recorded as a recent event.
The activity Nallagounder Palaniswami Arun was appointed as a Director was appointed as a Director on 29 Aug 2011 & has been associated with this company since 14 years 3 months . was completed.
Deivasigamani Palaniswamy was appointed as a Director was appointed as a Director on 29 Aug 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.
The CIN of Edg Pharmaceuticals (India) Private Limited is U24231TZ2011PTC017367.
Edg Pharmaceuticals (India) Private Limited is headquartered at 131, Kalidass Road Ramnagar, Coimbatore, Coimbatore, Tamil Nadu, 641009.
Edg Pharmaceuticals (India) Private Limited was incorporated on 29 August 2011.
The current directors of Edg Pharmaceuticals (India) Private Limited are
The primary industry of Edg Pharmaceuticals (India) Private Limited is Trade.
Edg Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Edg Pharmaceuticals (India) Private Limited is ₹5.00 M, and the paid-up capital is ₹3.70 M.
The compliance status of Edg Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
LIMITED.webp)
Company Details
+91-XXXXXXXXXX